Cargando...
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the safety and efficacy of anaplastic lymphoma kinase (ALK) inhibitors given as monotherapy to treat advanced ALK‐rearranged non‐small cell lung cancer (NSCLC).
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803015/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013453 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|